The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Actelsar HCT 80 mg/25 mg tablets

Actavis Group hfEU/1/13/817/029-041

Main Information

Trade NameActelsar HCT 80 mg/25 mg tablets
Active SubstancesHydrochlorothiazide
Dosage FormTablet
Licence HolderActavis Group hf
Licence NumberEU/1/13/817/029-041

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA07 telmisartan and diuretics


License statusAuthorised
Licence Issued13/03/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0050-100-039
Interchangeable List DocumentPDF of Interchangeable List
« Back